Moderna stock dropped 18% after the company slashed its 2025 revenue forecast by $1 billion, citing declining COVID vaccine demand, market competition, and other financial...
In a significant market development, shares of Nike and Foot Locker experienced a sharp decline following Nike’s announcement of a reduced revenue outlook and substantial...